Skip to content Skip to footer
Aflibercept-Ayyh: Benefits, Reviews, Info, Side Effects!
Rx Details
Aflibercept-Ayyh
Zaltrap, Eylea
Aflibercept
Prescription
Biologic
Drugs
Prescription Only
treatment of certain eye conditions, reduction of vision loss, improvement of visual acuity, management of age-related macular degeneration, treatment of diabetic macular edema, treatment of macular edema following retinal vein occlusion
Bleeding In The Eye, Blurred Vision, Cataracts, Dry Eyes, Eye Irritation, Eye Pain, Feeling Of Having Something In The Eye, Floaters In Vision, Headache, Increased Eye Pressure, Redness In The Eye, Sensitivity To Light, Watery Eyes
Aflibercept, marketed under the brand name Eylea among others, is typically used in the treatment of various eye conditions, such as age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). The dosage can vary depending on the specific condition being treated. For example, in the treatment of neovascular (wet) age-related macular degeneration, the typical dosage is 2 mg (0.05 mL) administered by intravitreal injection every 4 weeks (monthly) for the first 3 months, followed by 2 mg (0.05 mL) once every 8 weeks (2 months). However, some patients may require more frequent dosing based on their response to the treatment. It’s important to note that the exact dosage and frequency should be determined by a healthcare professional based on the individual patient’s condition and response to therapy. Always consult with a healthcare provider for the most appropriate treatment plan.
Wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy, macular edema following retinal vein occlusion
Safety profile of Aflibercept-Ayyh is generally favorable.
No Interactions Reported
$1,000 – $2,000
$1,200 per vial.

A Synopsis of

Aflibercept-Ayyh

Aflibercept-Ayyh is a medication that is commonly used in the treatment of certain types of cancer, specifically colorectal cancer and certain eye conditions such as macular degeneration. This drug works by blocking the growth of blood vessels that feed tumors, thereby slowing down or stopping the growth of cancer cells.

In the case of eye conditions, Aflibercept-Ayyh helps to reduce swelling and leakage in the retina, improving vision and preventing further damage to the eye. It is typically administered through injections directly into the affected area.

As with any medication, there are potential side effects associated with Aflibercept-Ayyh. These can include nausea, vomiting, diarrhea, high blood pressure, and fatigue. It is important to discuss any concerns or potential side effects with your healthcare provider before starting treatment with this medication.

It is also important to follow the dosing schedule provided by your healthcare provider and attend all scheduled appointments for injections. This will help ensure that you are receiving the full benefit of the medication and that any potential side effects are monitored and managed appropriately.

Overall, Aflibercept-Ayyh can be a valuable tool in the treatment of certain types of cancer and eye conditions. If you have been prescribed this medication, it is important to work closely with your healthcare team to ensure that you are receiving the best possible care and outcomes.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN